Universal reference book for medicines
Name of the preparation: KALTSINOVA (KALCINOVA)

Active substance: comb.
drug
Type: Complex of vitamins with macro elements

Manufacturer: KRKA (Slovenia)
Composition, form of production and packaging
?
Tablets are fruit round, with slight marbling, pink (crimson), or light yellow (pineapple), or light blue (blueberry), or light green (kiwi).
1 tab.

retinol palmitate (Vitamin A) 2 mg (1000 IU)

colcalciferol (Vit D3) 1 mg (100 IU)

ascorbic acid (vit C.) 15 mg

pyridoxine hydrochloride (vit B 6 ) 400 μg

calcium hydrogen phosphate dihydrate 430.4 mg

that corresponds to the content

Ca 2+ 100 mg

P 5+ 77 mg

Auxiliary substances: corn starch, povidone, citric acid anhydrous, polysorbate 80, magnesium stearate.

1 tablet of light green color (kiwi) additionally contains: dye green (dye quinoline yellow (E104), indigocarmine (E132)), flavor of kiwi, sucrose.

1 tablet of light blue color (blueberry) additionally contains: dye indigocarmine (E132), bilberry flavor, sucrose.

1 tablet of light yellow color (pineapple) additionally contains: dye quinoline yellow 06121 (E104), pineapple flavor, sucrose.

1 tablet of pink color (crimson) additionally contains: dye red charming (E129), raspberry flavor, sucrose.

9 pcs.
- blisters (3) - cardboard boxes.
INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2014.

PHARMACHOLOGIC EFFECT

Combined drug containing a complex of vitamins and minerals, which are important factors in metabolic processes.

Calcium is involved in the formation of bone tissue, blood clotting, transmission of nerve impulses, reduction of skeletal and smooth muscles, normal heart function.

Phosphorus, along with calcium, participates in the formation of bones and teeth, and also participates in the processes of energy metabolism.

For the correct mineralization of bones and teeth, in addition to calcium and phosphorus, which are building materials, vitamins, especially vitamin D 3(colcalciferol), which helps absorb calcium and phosphorus in the digestive organs and their proper distribution in the bone and dental tissues, must be consumed.

Vitamin A (retinol) is involved in the synthesis of various substances (proteins, lipids, mucopolysaccharides) and provides a normal function of the skin, mucous membranes, as well as the organ of vision.

Vitamin B 6 (pyridoxine) helps maintain the structure and function of bones, teeth, gums;
affects the erythropoiesis, promotes the normal functioning of the nervous system.
Vitamin C (ascorbic acid) is involved in the oxidation of a number of biologically active substances, regulation of metabolism in connective tissue, carbohydrate metabolism, blood clotting and tissue regeneration, stimulates the formation of steroid hormones, normalizes the permeability of capillaries.
Vitamin C increases the body's resistance to infections, reduces inflammatory reactions.
PHARMACOKINETICS

Data on the pharmacokinetics of the Kaltsinov preparation are not available.

INDICATIONS

The drug Kaltsinova recommended children:

- in the period of intensive growth and development;

- with intolerance to milk and dairy products;

- to strengthen and protect bones and teeth.

DOSING MODE

Children aged 3 to 4 years, the drug is prescribed for 2-3 tablets / day, children aged 4 years and older - 4-5 tab. / Day.

Tablets should be chewed or kept in the mouth until completely dissolved.

SIDE EFFECT

Allergic reactions, diarrhea and abdominal pain are possible .
In this case, it is necessary to interrupt the treatment with the Kaltsinov preparation and consult with the attending physician.
CONTRAINDICATIONS

- hypervitaminosis;

- hypercalciuria;

- hypercalcemia;

- renal failure of severe degree (QC less than 30 ml / min);

- Children's age up to 3 years;

- Hypersensitivity to the components of the drug.

With caution should apply the drug in diabetes mellitus.

APPLICATION FOR FUNCTIONS OF THE LIVER

Contraindicated in severe renal failure.

APPLICATION FOR CHILDREN

Contraindication: children under 3 years old.

SPECIAL INSTRUCTIONS

It is not recommended to prescribe the drug Kaltsinova in diabetes mellitus, tk.
the composition of the tablets includes sucrose.
Impact on the ability to drive vehicles and manage mechanisms

There is no known adverse effect on the ability to drive and work with other machinery.

OVERDOSE

Long-term use of the drug in high doses can lead to the development of hypervitaminosis A and D, as well as hypercalcemia, hypercalciuria.

Treatment: conduct symptomatic therapy.

DRUG INTERACTION

The drug Kaltsinova can not be taken simultaneously with drugs tetracycline and sodium fluoride, tk.
calcium reduces the absorption of these drugs. If it is necessary to use this combination, the interval between these drugs should be at least 3 hours.
Pyridoxine inhibits the activity of levodopa.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored in a place protected from light, inaccessible to children, at a temperature of no higher than 25 ° C.
Shelf life - 2 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!